January 1998
Volume 39, Issue 1
Free
Articles  |   January 1998
Autoantibodies against lacrimal gland M3 muscarinic acetylcholine receptors in patients with primary Sjögren's syndrome.
Author Affiliations
  • S Bacman
    CEFYBO (CONICET), CEMIC and Pharmacology Department, School of Dentistry, Buenos Aires University, Argentina.
  • C Perez Leiros
    CEFYBO (CONICET), CEMIC and Pharmacology Department, School of Dentistry, Buenos Aires University, Argentina.
  • L Sterin-Borda
    CEFYBO (CONICET), CEMIC and Pharmacology Department, School of Dentistry, Buenos Aires University, Argentina.
  • O Hubscher
    CEFYBO (CONICET), CEMIC and Pharmacology Department, School of Dentistry, Buenos Aires University, Argentina.
  • R Arana
    CEFYBO (CONICET), CEMIC and Pharmacology Department, School of Dentistry, Buenos Aires University, Argentina.
  • E Borda
    CEFYBO (CONICET), CEMIC and Pharmacology Department, School of Dentistry, Buenos Aires University, Argentina.
Investigative Ophthalmology & Visual Science January 1998, Vol.39, 151-156. doi:
  • Views
  • PDF
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      S Bacman, C Perez Leiros, L Sterin-Borda, O Hubscher, R Arana, E Borda; Autoantibodies against lacrimal gland M3 muscarinic acetylcholine receptors in patients with primary Sjögren's syndrome.. Invest. Ophthalmol. Vis. Sci. 1998;39(1):151-156.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

PURPOSE: The authors demonstrated that immunoglobulin G, present in the sera of patients with primary Sjögren syndrome (pSS), could recognize and activate muscarinic acetylcholine receptors (mAChRs) of rat exorbital acrimal gland. METHODS: Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), immunoblotting, and radioligand binding and biologic assays were used to demonstrate autoantibodies against mAChRs. RESULTS: These autoantibodies recognized by means of SDS-PAGE and immunoblotting assay a band of approximately 70 kDa expressed on lacrimal gland membranes that comigrated with the peak of labeled mAChRs. Moreover, pSS IgG were able to inhibit, in an irreversible manner, the binding of [3H]quinuclidinyl benzilate to mAChRs of rat exorbital lacrimal glands and to simulate the biologic effect of mAChR agonists, because they trigger the activation of phosphoinositide turnover. Atropine and 4-diphenylacetoxy-N-methylpiperidine methiodide blocked the effect and carbachol mimicked it, confirming that the M3 subtype mAChRs mediated pSS IgG action. As control, IgG from sera of women without pSS gave negative results on immunoblotting, binding, and biologic assays, thus demonstrating the specificity of the reaction. CONCLUSIONS: Autoantibodies against mAChRs may be considered among the serum factors implicated in the pathophysiology of the development of pSS dry eyes.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×